These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3339851)

  • 1. [Policies for clinical trials in cancer].
    Suemasu K
    Gan No Rinsho; 1988 Jan; 34(1):7-12. PubMed ID: 3339851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials].
    Shimoyama M; Tajima K
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2507-18. PubMed ID: 8279849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ; McKinney MM; Carpenter WR
    Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring clinical research. A report from the Childrens Cancer Study Group.
    Stowe SM; Hammond GD; Chard R; Hornberger JA; Honour RC; Sposto R; Weiner JM
    Am J Clin Oncol; 1984 Oct; 7(5):557-66. PubMed ID: 6507379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of clinical trials and interim analysis. 1. Monitoring committee].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):345-9. PubMed ID: 1494799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping clinical trials by design.
    Whitehead J
    Nat Rev Drug Discov; 2004 Nov; 3(11):973-7. PubMed ID: 15520819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim analyses in clinical trials.
    Emerson SS; Fleming TR
    Oncology (Williston Park); 1990 Mar; 4(3):126-33; discussion 134, 136. PubMed ID: 2144441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is a clinical trial protocol?
    Cipriani A; Barbui C
    Epidemiol Psichiatr Soc; 2010; 19(2):116-7. PubMed ID: 20815294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems of protocol practice in Japan.
    Nose Y; Akazawa K; Hayashi Y; Shimada M; Watanabe Y; Higashi H; Moriguchi S; Fujisawa K
    Jpn Hosp; 1991 Jul; 10():19-24. PubMed ID: 10111640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II clinical trials in patients with lung cancer].
    Shinkai T; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():232-44. PubMed ID: 8007470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analyses of clinical trials in cancer: are they helpful to policy makers?
    Bennett CL; Armitage JL; LeSage S; Gulati SC; Armitage JO; Gorin NC
    Stem Cells; 1994 Jul; 12(4):424-9. PubMed ID: 7951008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Oncology Groups in Japan: experience of the Japan Adult Leukemia Study Group (JALSG)].
    Ohno R
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2519-24. PubMed ID: 8279850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality issues in clinical research and the implications on health policy (QICRHP).
    Njie VP; Thomas AC
    J Prof Nurs; 2001; 17(5):233-42. PubMed ID: 11559879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.